Michael Chang is a Principal Scientist at Kenvue since May 2023, previously serving in a similar role at Johnson & Johnson from April 2012 to May 2023. At Johnson & Johnson, Michael was responsible for formulating new facial leave-on products for North America, particularly supporting the Neutrogena and Aveeno brands, and contributed to the franchise development and strategy for the Neutrogena Rapid line through end-to-end product development to manufacturing. Michael's career also includes experience as a Senior Scientist and Scientist II at Johnson & Johnson. Michael holds a Bachelor of Science degree in Biomedical/Medical Engineering from Rutgers University and a Master's degree in the same field from Stevens Institute of Technology.
This person is not in the org chart
This person is not in any teams
This person is not in any offices